Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents.
about
Integrative meta-analysis of differential gene expression in acute myeloid leukemiaThe thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis.Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer.18β-Glycyrrhetinic acid suppresses cell proliferation through inhibiting thromboxane synthase in non-small cell lung cancer.Regulation of the tumor suppressor FOXO3 by the thromboxane-A2 receptors in urothelial cancerThromboxane A2 Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase (MAPK)-mediated G2/M Progression Delay and Cell Apoptosis.Hepatic stellate cells promote hepatocyte engraftment in rat liver after prostaglandin-endoperoxide synthase inhibitionProstanoids receptors signaling in different diseases/cancers progression.Tobacco carcinogen NNK-induced lung cancer animal models and associated carcinogenic mechanisms.Thromboxane A2 exerts promoting effects on cell proliferation through mediating cyclooxygenase-2 signal in lung adenocarcinoma cells.Functional analysis of human thromboxane synthase polymorphic variants.Thromboxane A2 modulates cisplatin-induced apoptosis through a Siva1-dependent mechanism.Inhibition of thromboxane synthase activity improves glioblastoma response to alkylation chemotherapy.Genomic polymorphisms of SLC29A3 associated with overall survival in advanced non-small-cell lung cancer treated with gemcitabine.
P2860
Q33538043-93502C7B-F023-495F-BE4C-2CA8DFBA7C61Q34228685-BA8679A8-59A3-48C8-AB2C-07409A6D44CCQ34781725-78A8CD80-6AFE-4FAF-8813-F975A3B3D2F5Q35138733-9A26D8DA-3560-4D5C-86A0-72CB8092185CQ35244124-6EBD6D60-54B1-4040-B864-8BB1CB813206Q36744591-B8C04F1C-F45D-4C81-866E-8CC70F439FEEQ37219924-2D4C92C3-000C-4B40-941E-E7D32A23B7C8Q38074716-994C5884-A1B5-4585-8805-1936199774FCQ38514782-D97867A4-B9E2-4119-A1D5-A8D133837811Q39037809-7164A08D-3A0E-4A8B-AE10-992A37889229Q40757621-C3C68F19-6EA1-42C4-BE98-28E1E22809EEQ41869097-CBAE5AD3-BF1B-4E99-ACA1-CEDA11838F9CQ42172477-C0425923-155D-41DC-A937-8D0AA459D3EEQ45220444-FB7E9AAA-CD8E-4B63-B5DE-58FB6DA9D4B5
P2860
Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Inhibition of thromboxane synt ...... es to chemotherapeutic agents.
@ast
Inhibition of thromboxane synt ...... es to chemotherapeutic agents.
@en
Inhibition of thromboxane synt ...... es to chemotherapeutic agents.
@nl
type
label
Inhibition of thromboxane synt ...... es to chemotherapeutic agents.
@ast
Inhibition of thromboxane synt ...... es to chemotherapeutic agents.
@en
Inhibition of thromboxane synt ...... es to chemotherapeutic agents.
@nl
prefLabel
Inhibition of thromboxane synt ...... es to chemotherapeutic agents.
@ast
Inhibition of thromboxane synt ...... es to chemotherapeutic agents.
@en
Inhibition of thromboxane synt ...... es to chemotherapeutic agents.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of thromboxane synt ...... ses to chemotherapeutic agents
@en
P2093
P2860
P2888
P356
10.1038/SJ.ONC.1210629
P407
P577
2007-07-02T00:00:00Z
P5875
P6179
1052307717